ZA200706613B - Process - Google Patents

Process

Info

Publication number
ZA200706613B
ZA200706613B ZA200706613A ZA200706613A ZA200706613B ZA 200706613 B ZA200706613 B ZA 200706613B ZA 200706613 A ZA200706613 A ZA 200706613A ZA 200706613 A ZA200706613 A ZA 200706613A ZA 200706613 B ZA200706613 B ZA 200706613B
Authority
ZA
South Africa
Application number
ZA200706613A
Other languages
English (en)
Inventor
Kankan Rajendra Narayanrao
Pathi L Srinivas
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of ZA200706613B publication Critical patent/ZA200706613B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
ZA200706613A 2004-12-16 2005-12-15 Process ZA200706613B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1350MU2004 2004-12-16

Publications (1)

Publication Number Publication Date
ZA200706613B true ZA200706613B (en) 2009-03-25

Family

ID=35912924

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200706613A ZA200706613B (en) 2004-12-16 2005-12-15 Process

Country Status (10)

Country Link
US (1) US8691995B2 (tr)
JP (1) JP5355893B2 (tr)
KR (1) KR101370844B1 (tr)
AU (1) AU2005315390B2 (tr)
CA (1) CA2591405A1 (tr)
DE (1) DE112005003147T5 (tr)
GB (1) GB2436262B (tr)
TR (1) TR200705749T1 (tr)
WO (1) WO2006064249A2 (tr)
ZA (1) ZA200706613B (tr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2528993A1 (en) 2003-06-10 2004-12-23 Teva Pharmaceutical Industries Ltd. Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole
WO2009010937A1 (en) 2007-07-17 2009-01-22 Ranbaxy Laboratories Limited Process for the preparation op pantoprazole sodium and pantoprazole sodium sesquihydrate
CN102796078B (zh) * 2012-08-24 2014-10-29 杭州澳亚生物技术有限公司 一种泮托拉唑化合物、制备方法及其药物制剂
CN103012373B (zh) * 2013-01-16 2014-11-05 湖北济生医药有限公司 一种泮托拉唑钠化合物及其药物组合物
CN103214459B (zh) * 2013-03-22 2014-11-12 海南中化联合制药工业股份有限公司 泮托拉唑钠结晶化合物，其药物组合物及其制备方法
CN106467514A (zh) * 2016-09-12 2017-03-01 杭州中美华东制药有限公司 一种制备高稳定性泮托拉唑钠水合物的方法
CN111057044A (zh) * 2019-12-19 2020-04-24 北京民康百草医药科技有限公司 一种泮托拉唑钠倍半水合物单一晶型的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
ZA854287B (en) 1984-06-16 1986-02-26 Byk Gulden Lomberg Chem Fab Dialkoxypyridines,process for their preparation,their use and medicaments containing them
DE4018642C2 (de) 1990-06-11 1993-11-25 Byk Gulden Lomberg Chem Fab Neue Salzform des 5-Difluormethoxy-2-[(3,4-dimethoxy-2-pyridyl) methylsulfinyl]-1H-benzimitazol-Natriumsalzes
SE521100C2 (sv) 1995-12-15 2003-09-30 Astra Ab Förfarande för framställning av en bensimidazolförening
WO1997029103A2 (en) 1996-02-06 1997-08-14 Pdi-Research Laboratories, Inc. Synthesis of omeprazole-type pyridine derivatives and intermediates thereof
SK283805B6 (sk) 1996-09-09 2004-02-03 Slovakofarma, A. S. Spôsob prípravy omeprazolu
ES2166269B1 (es) * 1999-07-14 2003-04-01 Sint Quimica Sa Nuevo procedimiento de obtencion de derivados de 2-(2-piridinilmetilsulfinil)-1h-benzimidazol.
ES2185459B1 (es) * 2000-10-02 2003-12-16 Dinamite Dipharma Spa Procedimiento para la obtencion de pantoprazol y compuestos intermedios para el mismo.
US7129358B2 (en) 2001-02-02 2006-10-31 Teva Pharmaceutical Industries Ltd. Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1H-benzimidazoles
CA2446904A1 (en) * 2001-05-24 2003-04-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
US6933389B2 (en) * 2002-09-02 2005-08-23 Dr. Reddy's Laboratories Limited Process for preparation of crystalline form-1 of pantoprazole sodium sesquihydrate
SE0203092D0 (en) 2002-10-18 2002-10-18 Astrazeneca Ab Method for the synthesis of a benzimidazole compound
WO2004056804A2 (en) * 2002-12-19 2004-07-08 Teva Pharmaceutical Industries Ltd. Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
WO2004063188A1 (en) * 2003-01-15 2004-07-29 Cipla Limited Paharmaceutical process and compounds prepared thereby
ITMI20031813A1 (it) 2003-09-23 2005-03-24 Dinamite Dipharma S P A In Forma A Bbreviata Diph Procedimento per la preparazione di pantoprazolo e suoi sali.

Also Published As

Publication number Publication date
GB2436262A (en) 2007-09-19
TR200705749T1 (tr) 2007-12-24
US20100016605A1 (en) 2010-01-21
US8691995B2 (en) 2014-04-08
WO2006064249A2 (en) 2006-06-22
WO2006064249A3 (en) 2006-10-05
GB0713385D0 (en) 2007-08-22
GB2436262B (en) 2010-01-20
JP2008524190A (ja) 2008-07-10
AU2005315390B2 (en) 2011-10-27
AU2005315390A1 (en) 2006-06-22
KR101370844B1 (ko) 2014-03-07
KR20070107001A (ko) 2007-11-06
DE112005003147T5 (de) 2008-01-17
CA2591405A1 (en) 2006-06-22
JP5355893B2 (ja) 2013-11-27

Similar Documents

Publication Publication Date Title
GB0416001D0 (en) Process
GB0407329D0 (en) Process
GB0418654D0 (en) Process
GB0418046D0 (en) Eantioselective process
GB0404793D0 (en) Process
GB0421928D0 (en) Process
GB0414847D0 (en) Process
GB0413053D0 (en) Process
GB0419075D0 (en) Process
GB0420563D0 (en) Process
ZA200706613B (en) Process
GB0406894D0 (en) Process
GB0410289D0 (en) Process
GB0412875D0 (en) Process
GB0414335D0 (en) Process
GB0411583D0 (en) Process
GB0423464D0 (en) Process
GB0411185D0 (en) Process
GB0420561D0 (en) Process
GB0420564D0 (en) Process
GB0413322D0 (en) Process
GB0424002D0 (en) Process
GB0424000D0 (en) Process
GB0410276D0 (en) Process
GB0406069D0 (en) Process